Cargando…

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

BACKGROUND: Alzheimer’s disease (AD) is characterized not only by cognitive and functional decline, but also often by the presence of neuropsychiatric symptoms. Apathy, which can be defined as a lack of motivation, is one of the most prevalent neuropsychiatric symptoms in AD and typically leads to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherer, Roberta W., Drye, Lea, Mintzer, Jacobo, Lanctôt, Krista, Rosenberg, Paul, Herrmann, Nathan, Padala, Prasad, Brawman-Mintzer, Olga, Burke, William, Craft, Suzanne, Lerner, Alan J., Levey, Allan, Porsteinsson, Anton, van Dyck, Christopher H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774109/
https://www.ncbi.nlm.nih.gov/pubmed/29347996
http://dx.doi.org/10.1186/s13063-017-2406-5